IndraLab

Statements

MAPT inhibits SCN1A. 2 / 2

| 2

reach

"Tau ablation reduced the percentage of Scn1a RX/+ mice with seizures 2.7-fold to 16% without affecting seizure severity or duration in those mice that did develop seizures."

25042160

➶

reach

"Tau Reduction Lowers Epileptic Activity and Network Hyperexcitability in Scn1a RX/+ Mice."

25042160

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

MAPT inhibits SCN1A. 2 / 2

INDRA sources:

Databases

Reading